Literature DB >> 22264670

A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.

Mark J Eliason1, Sancy A Leachman, Bing-jian Feng, Mary E Schwartz, C David Hansen.   

Abstract

BACKGROUND: Pachyonychia congenita (PC) is a group of autosomal dominant keratinizing disorders caused by a mutation in one of 4 keratin genes. Previous classification schemes have relied on data from case series and case reports. Most patients in these reports were not genetically tested for PC.
OBJECTIVE: We sought to clarify the prevalence of clinical features associated with PC.
METHODS: We surveyed 254 individuals with confirmed keratin mutations regarding their experience with clinical findings associated with PC. Statistical comparison of the groups by keratin mutation was performed using logistic regression analysis.
RESULTS: Although the onset of clinical symptoms varied considerably among our patients, a diagnostic triad of toenail thickening, plantar keratoderma, and plantar pain was reported by 97% of patients with PC by age 10 years. Plantar pain had the most profound impact on quality of life. Other clinical findings reported by our patients included fingernail dystrophy, oral leukokeratosis, palmar keratoderma, follicular hyperkeratosis, hyperhidrosis, cysts, hoarseness, and natal teeth. We observed a higher likelihood of oral leukokeratosis in individuals harboring KRT6A mutations, and a strong association of natal teeth and cysts in carriers of a KRT17 mutation. Most keratin subgroups expressed a mixed constellation of findings historically reported as PC-1 and PC-2. LIMITATIONS: Data were obtained through questionnaires, not by direct examination. Patients were self- or physician-referred.
CONCLUSIONS: We propose a new classification for PC based on the specific keratin gene affected to help clinicians improve their diagnostic and prognostic accuracy, correct spurious associations, and improve therapeutic development.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22264670     DOI: 10.1016/j.jaad.2011.12.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.

Authors:  Kelly A Edwards; Sharon F Terry; Dana Gold; Elizabeth J Horn; Mary Schwartz; Molly Stuart; Suzanne D Vernon
Journal:  Biopreserv Biobank       Date:  2016-04-08       Impact factor: 2.300

Review 2.  Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.

Authors:  A G Zieman; P A Coulombe
Journal:  Br J Dermatol       Date:  2019-07-24       Impact factor: 9.302

3.  First Report of Pachyonychia Congenita Type PC-K6a in the Romanian Population.

Authors:  Anca Chiriac; Cristina Rusu; Alina Murgu; Anca E Chiriac; Neil J Wilson; Frances J D Smith
Journal:  Maedica (Buchar)       Date:  2017-06

4.  Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteins.

Authors:  Thomas M Harris; Peicheng Du; Nicole Kawachi; Thomas J Belbin; Yanhua Wang; Nicolas F Schlecht; Thomas J Ow; Christian E Keller; Geoffrey J Childs; Richard V Smith; Ruth Hogue Angeletti; Michael B Prystowsky; Jihyeon Lim
Journal:  Arch Pathol Lab Med       Date:  2014-10-08       Impact factor: 5.534

5.  Gene expression profiling in pachyonychia congenita skin.

Authors:  Yu-An Cao; Robyn P Hickerson; Brandon L Seegmiller; Dmitry Grapov; Maren M Gross; Marc R Bessette; Brett S Phinney; Manuel A Flores; Tycho J Speaker; Annaleen Vermeulen; Albert A Bravo; Anna L Bruckner; Leonard M Milstone; Mary E Schwartz; Robert H Rice; Roger L Kaspar
Journal:  J Dermatol Sci       Date:  2015-01-14       Impact factor: 4.563

6.  Proteomic profiling of Pachyonychia congenita plantar callus.

Authors:  Robert H Rice; Blythe P Durbin-Johnson; Michelle Salemi; Mary E Schwartz; David M Rocke; Brett S Phinney
Journal:  J Proteomics       Date:  2017-06-23       Impact factor: 4.044

Review 7.  [Syndroms associated with benign skin tumors].

Authors:  George-Sorin Tiplica; Klaus Fritz; Alexandra Irina Butacu; Loredana Ungureanu; Carmen Maria Sălăvăstru
Journal:  Hautarzt       Date:  2022-01-25       Impact factor: 0.751

Review 8.  Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.

Authors:  Michael Zakrewsky; Sunny Kumar; Samir Mitragotri
Journal:  J Control Release       Date:  2015-09-15       Impact factor: 9.776

9.  Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.

Authors:  Michelle L Kerns; Jill M C Hakim; Rosemary G Lu; Yajuan Guo; Andreas Berroth; Roger L Kaspar; Pierre A Coulombe
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

10.  Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.

Authors:  Albert G Wu; Shari R Lipner
Journal:  Skin Appendage Disord       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.